

"Global leader in specialized diagnostics for hemostasis, acute care and autoimmunity"
Werfen develops in vitro diagnostic systems that help clinicians diagnose and treat complex medical conditions. With specialized solutions across hemostasis, acute care, transfusion, autoimmunity and transplant medicine, the company serves clinical laboratories, intensive care units and emergency departments. Products include testing systems, molecular assays and software designed to improve accuracy and efficiency. Founded in Barcelona in 1966, Werfen operates in more than 30 countries with over 7,000 employees. As a family owned business, it invests in research to anticipate laboratory needs. Its innovations help reduce costs, save time in critical care and support better outcomes, from safe transfusions to transplant monitoring.


7000
Team Members
1966
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where advanced diagnostic testing enables timely, accurate medical decisions that improve patient outcomes and create healthier societies across every community.
Werfen develops meaningful innovations that truly enhance patient care and help create healthier societies worldwide.